Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a-Reference-Cited by-同舟云学术

Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a

Published:2016-08-17 Issue:40 Volume:7 Page:65052-65066
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cui Xiao¹²,Li Zhao¹,Gao Jie¹,Gao Peng-Ji¹,Ni Yan-bing¹,Zhu Ji-Ye¹

Affiliation:

1. Department of Hepatobilliary Surgery, Beijing Key Surgical Basic Research Laboratory of Liver Cirrhosis and Liver Cancer, Peking University People's Hospital, Beijing 100044, China

2. Department of General Surgery, The Second Hospital of Anhui Medical University, Hefei 230601, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA;Cell Biochemistry and Biophysics;2024-07-10

2. Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma;Hepatology International;2024-07-04

3. Echinacea purpurea polysaccharide intervene in hepatocellular carcinoma via modulation of gut microbiota to inhibit TLR4/NF-κB pathway;International Journal of Biological Macromolecules;2024-03

4. Clinical significance of circulating biomarkers of immune checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma;2024-01-10

5. The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers;Cells;2023-05-17